mRNA vaccines: Four major clinical trial readouts to watch in 2023
After their success in Covid-19, can mRNA vaccines breakthrough in influenza, herpes, and even cancer?

After their success in Covid-19, can mRNA vaccines breakthrough in influenza, herpes, and even cancer?
The Phase I/II clinical trial will evaluate the safety and immunogenicity of the vaccine.
The global pharmaceutical industry experienced a 10% rise in new job postings related to social responsibility in Q3 2022 compared…
Dyadic initiates subject dosing in Phase I trial of Covid-19 booster
Tevogen Bio reports positive data from Covid-19 T cell therapy trial
Cyrano to initiate Phase II trial of nasal spray therapy for Hyposmia
Shionogi commences Phase I/II/III and Phase III trials of Covid-19 vaccine